Serum Parathyroid Hormone Suppression by Intravenous 1,25-Dihydroxyvitamin D3 in Patients on Maintenance Haemodialysis

Zalmai Rassoul,Dujanah Mousa,Mohammed Abdur Rehman,Abdalla H. Abdalla,Fahad Hawas,William Popovich,Munir Gaisoum,Mohammed Al Sulaiman,Abdulla Al-Khader

Serum Parathyroid Hormone Suppression by Intravenous 1,25-Dihydroxyvitamin D3 in Patients on Maintenance Haemodialysis

1995

Zalmai Rassoul
Dujanah Mousa
Mohammed Abdur Rehman
Abdalla H. Abdalla
Fahad Hawas
William Popovich
Munir Gaisoum
Mohammed Al Sulaiman
Abdulla Al-Khader

Secondary hyperparathyroidism in patients with end-stage renal disease is characterised by elevated circulating levels of parathyroid hormone, due to inadequate synthesis of calcitriol, the active met

Keywords:

Vitamin D and neurology
Hyperparathyroidism
Nephropathy
Calcitriol
Parathyroid hormone
Side effect
Secondary hyperparathyroidism
Endocrinology
Hemodialysis
Internal medicine
Medicine
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations